Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |